ApoE: The link between Alzheimer's-related glucose hypometabolism and Aβ deposition?

Medical Hypotheses

Volumn 78, Issue 4, 2012, Pages 494-496

  Patil, Sachin P ^a   Ballard, Ryan ^a   Sanchez, Sheena ^a   Osborn, James ^a   Santangelo Jr , David ^a  

^a WIDENER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; INSULINASE; LIVER X RECEPTOR;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; GLUCOSE METABOLISM; LIPID METABOLISM; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN FUNCTION; PROTEIN TRANSPORT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; BRAIN; GLUCOSE; HUMANS; LIPID METABOLISM; MODELS, BIOLOGICAL;

EID: 84858161222     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.01.015     Document Type: Article

References (21)

1. Smith M.A. Alzheimer disease. Int Rev Neurobiol 1998, 42:1-54.
2. Wang D.C., Chen S.S., Lee Y.C., Chen T.J. Amyloid-beta at sublethal level impairs BDNF-induced arc expression in cortical neurons. Neurosci Lett 2006, 398:78-82.
3. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
4. Shah R.S., Lee H.G., Xiongwei Z., Perry G., Smith M.A., Castellani R.J. Current approaches in the treatment of Alzheimer's disease. Biomed Pharmacother 2008, 62:199-207.
5. Chartier-Harlin M.C., Crawford F., Houlden H., Warren A., Hughes D., Fidani L., et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 1991, 353:844-846.
6. Mawuenyega K.G., Sigurdson W., Ovod V., Munsell L., Kasten T., Morris J.C., et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 2010, 330:1774.
7. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. Eur J Nucl Med Mol Imaging 2005, 32:486-510.
8. Hoyer S. Abnormalities of glucose metabolism in Alzheimer's disease. Ann NY Acad Sci 1991, 640:53-58.
9. Munch G., Schinzel R., Loske C., Wong A., Durany N., Li J.J., et al. Alzheimer's disease - synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J Neural Transm 1998, 105:439-461.
10. Hunt A., Schönknecht P., Henze M., Seidl U., Haberkorn U., Schröder J. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res 2007, 155:147-154.
11. Gibson G.E. Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease. Free Radic Biol Med 2002, 32:1061-1070.
12. Vlassenko A.G., Vaishnavi S.N., Couture L., Sacco D., Shannon B.J., Mach R.H., et al. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc Natl Acad Sci USA 2010, 107:17763-17767.
13. Jiang Q., Daniel Lee C.Y., Mandrekar S., Wilkinson B., Cramer P., Zelcer N., et al. ApoE promotes the proteolytic degradation of Aβ. Neuron 2008, 58:681-693.
14. Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B., et al. Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid beta peptides. Biochem J 2000, 348:359-365.
15. Valla J., Yaari R., Wolf A.B., Kusne Y., Beach T.G., Roher A.E., et al. Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the ApoE e4 allele, the major late-onset Alzheimer's susceptibility gene. J Alzheimers Dis 2010, 22(1):307-313.
16. Sheline Y.I., Morris J.C., Snyder A.Z., Price J.L., Yan Z., D'Angelo G., et al. ApoE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Abeta42. J Neurosci 2010, 30(50):17035-17040.
17. Jiang X.C., Beyer T.P., Li Z., Liu J., Quan W., Schmidt R.J., et al. Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression. J Biol Chem 2003, 278:49072-49078.
18. Mitro N., Mak P.A., Vargas L., Godio C., Hampton E., Molteni V., et al. The nuclear receptor LXR is a glucose sensor. Nature 2007, 445:219-223.
19. Kawarabayashi T., Shoji M., Younkin L.H., Wen-Lang L., Dickson D.W., Murakami T., et al. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 2004, 24(15):3801-3809.
20. Liang W.S., Chen K., Lee W., Sidhar K., Corneveaux J.J., Allen A.N., et al. Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's disease-affected brain regions in cognitively normal ApoEε4 carriers. Neuroimage 2011, 54:1896-1902.
21. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., et al. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci USA 2005, 102:8299-8302.